Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Studies have raised concern about an association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and an increased risk of autism spectrum disorders in the offspring. METHODS: We conducted a cohort study of all singleton live births in Denmark from 1996 through 2005 (626,875 births), with follow-up through 2009. Using Danish population registries, we linked information on maternal use of SSRIs before and during pregnancy, autism spectrum disorders diagnosed in the offspring, and a range of potential confounders. We used a survival analysis of the time to diagnosis in the offspring with Poisson regression to estimate rate ratios of autism spectrum disorders according to maternal use of SSRIs. RESULTS: During 5,057,282 person-years of follow-up, we identified 3892 cases of autism spectrum disorder (incidence rate, 77.0 per 100,000 person-years). A total of 52 cases during 42,400 person-years of follow-up involved offspring of women who were exposed to SSRIs during their pregnancy (incidence rate, 122.6 per 100,000 person-years). As compared with no use of SSRIs both before and during pregnancy, use during pregnancy was not associated with a significantly increased risk of autism spectrum disorders (fully adjusted rate ratio, 1.20; 95% confidence interval [CI], 0.90 to 1.61). Among women who received SSRIs before pregnancy but not during pregnancy, the corresponding fully adjusted rate ratio was 1.46 (95% CI, 1.17 to 1.81). CONCLUSIONS: We did not detect a significant association between maternal use of SSRIs during pregnancy and autism spectrum disorder in the offspring. On the basis of the upper boundary of the confidence interval, our study could not rule out a relative risk up to 1.61, and therefore the association warrants further study. (Funded by the Danish Health and Medicines Authority.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our findings of no association between prenatal SSRI exposure and ASD are consistent with the conclusions of several large, population-based studies that specifically address confounding by indication (19–26, 42).”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [20]
In the citing paper
“Associations between ASD and maternal psychiatric conditions preceding or during pregnancy (20, 45, 46), including depression (24, 43, 44, 47), schizophrenia (48, 49), anxiety (50), and personality disorders (48), are commonly reported in the literature.”
From Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders (2021) · cites this paper as [20]
In the citing paper
“Subsequently, one health claims-based study5 and one registry-based study6 associated in utero exposure to antidepressants with autism liability in children, while a recent large-scale Danish registry-based study did not replicate this association7.”
In the citing paper
“Our results are also consistent with the most recent and largest registry-based investigation 7, in that both studies failed to identify risk specifically among SSRI-treated patients.”
In the citing paper
“there was a total of 15 observational studies measuring ASD as an outcome [16–19, 25–35].”
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
The Danish Civil Registration System
Pedersen, C. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810387965 · Cited by 4,632
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
The Danish National Prescription Registry
Wallach Kildemoes, H., Toft Sørensen, H., & Hallas, J. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394717 · Cited by 2,467
Epidemiology of Pervasive Developmental Disorders
Fombonne, E. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819e7203 · Cited by 1,971
The Danish Psychiatric Central Research Register
Mors, O., Perto, G. P., & Mortensen, P. B. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810395825 · Cited by 1,589
Jensen, V. M., & Rasmussen, A. W. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494810394715 · Cited by 1,471
- Statistical Models for Epidemiology
(2013) · Bayesian Methods in Epidemiology · doi:10.1201/b15382-9 · Cited by 1,346
Alder, J., Fink, N., Bitzer, J., Hösli, I., & Holzgreve, W. (2007) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050701209560 · Cited by 872
Research works printed but not linked: 4
- Knudsen LB, 1998, Dan Med Bull, 45, 320
- Jorgensen FS, 2003, Ugeskr Laeger, 165, 4404
- Poisson and logistic regression. In: Clayton D, Hills M. Statistical models in epidemiology. Oxford, England: Oxford University Press, 1993;227-36.
- 2012, MMWR Surveill Summ, 61, 1
Cited by
Lord, C., Brugha, T. S., Charman, T., Cusack, J., Dumas, G., Frazier, T., Jones, E. J. H., Jones, R. M., Pickles, A., State, M. W., et al. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0138-4 · Cited by 1,859
Non-psychotic mental disorders in the perinatal period
Howard, L. M., Molyneaux, E., Dennis, C.-L., Rochat, T., Stein, A., & Milgrom, J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61276-9 · Cited by 1,328
Autism Spectrum Disorder: Classification, diagnosis and therapy
Sharma, S. R., Gonda, X., & Tarazi, F. I. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.007 · Cited by 673
Kocherlakota, P. (2014) · Pediatrics · doi:10.1542/peds.2013-3524 · Cited by 612
The serotonin system in autism spectrum disorder: From biomarker to animal models
Muller, C. L., Anacker, A. M. J., & Veenstra-VanderWeele, J. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.010 · Cited by 531
“, 2013), whereas a large study in the Danish population found no significant association (Hviid et al., 2013).”
Result
Metadata
- Authors
- Hviid, A., Melbye, M., & Pasternak, B.
- Affiliations
- Statens Serum Institut (DK)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-12-19
- Volume
- 369
- Issue
- 25
- Pages
- 2406-2415
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2061360351
- Cited by
- 195
- References
- 24
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 4 · 2023: 5 · 2022: 7 · 2021: 10 · 2020: 16 · 2019: 21 · 2018: 18 · 2017: 30 · 2016: 30 · 2015: 24 · 2014: 15 · 2013: 1
- FWCI
- 23.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Keywords
- selective serotonin reuptake inhibitors, autism spectrum disorder, maternal antidepressant use, pregnancy, prenatal drug exposure, antidepressant safety in pregnancy
- MeSH terms
- Adult, Child Development Disorders, Pervasive, Denmark, Female, Follow-Up Studies, Humans, Pregnancy, Prenatal Exposure Delayed Effects, Registries, Risk, Incidence, Confidence Intervals, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism. https://app.cochat.ai/papers/10.1056/nejmoa1301449
- The paper
- Hviid, A., Melbye, M., & Pasternak, B. (2013). Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1301449
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.